Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Oral sophocarpine protects rat heart against pressure overload-induced cardiac fibrosis.

Li J, Li L, Chu H, Sun X, Ge Z.

Pharm Biol. 2014 Aug;52(8):1045-51. doi: 10.3109/13880209.2013.877038.

PMID:
24618002
2.

Sophocarpine administration preserves myocardial function from ischemia-reperfusion in rats via NF-κB inactivation.

Li C, Gao Y, Tian J, Shen J, Xing Y, Liu Z.

J Ethnopharmacol. 2011 Jun 1;135(3):620-5. doi: 10.1016/j.jep.2011.03.052.

PMID:
21459139
3.

Triptolide protects rat heart against pressure overload-induced cardiac fibrosis.

Zhang Z, Qu X, Ni Y, Zhang K, Dong Z, Yan X, Qin J, Sun H, Ding Y, Zhao P, Gong K.

Int J Cardiol. 2013 Oct 3;168(3):2498-505. doi: 10.1016/j.ijcard.2013.03.001.

PMID:
23541609
4.

Tanshinone II-A attenuates cardiac fibrosis and modulates collagen metabolism in rats with renovascular hypertension.

Fang J, Xu SW, Wang P, Tang FT, Zhou SG, Gao J, Chen JW, Huang HQ, Liu PQ.

Phytomedicine. 2010 Dec 15;18(1):58-64. doi: 10.1016/j.phymed.2010.06.002.

PMID:
20638255
5.

Attenuated development of cardiac fibrosis in left ventricular pressure overload by SM16, an orally active inhibitor of ALK5.

Engebretsen KV, Skårdal K, Bjørnstad S, Marstein HS, Skrbic B, Sjaastad I, Christensen G, Bjørnstad JL, Tønnessen T.

J Mol Cell Cardiol. 2014 Nov;76:148-57. doi: 10.1016/j.yjmcc.2014.08.008.

PMID:
25169971
6.

Qishenyiqi protects ligation-induced left ventricular remodeling by attenuating inflammation and fibrosis via STAT3 and NF-κB signaling pathway.

Li C, Wang Y, Qiu Q, Shi T, Wu Y, Han J, Chai X, Wang W.

PLoS One. 2014 Aug 14;9(8):e104255. doi: 10.1371/journal.pone.0104255.

7.

Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1β upregulation via nuclear factor κB activation.

Higashikuni Y, Tanaka K, Kato M, Nureki O, Hirata Y, Nagai R, Komuro I, Sata M.

J Am Heart Assoc. 2013 Nov 18;2(6):e000267. doi: 10.1161/JAHA.113.000267.

8.

Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-κB.

Verma SK, Krishnamurthy P, Barefield D, Singh N, Gupta R, Lambers E, Thal M, Mackie A, Hoxha E, Ramirez V, Qin G, Sadayappan S, Ghosh AK, Kishore R.

Circulation. 2012 Jul 24;126(4):418-29. doi: 10.1161/CIRCULATIONAHA.112.112185.

9.

Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy.

Westermann D, Van Linthout S, Dhayat S, Dhayat N, Schmidt A, Noutsias M, Song XY, Spillmann F, Riad A, Schultheiss HP, Tschöpe C.

Basic Res Cardiol. 2007 Nov;102(6):500-7.

PMID:
17909696
10.

N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin.

Liu YH, D'Ambrosio M, Liao TD, Peng H, Rhaleb NE, Sharma U, André S, Gabius HJ, Carretero OA.

Am J Physiol Heart Circ Physiol. 2009 Feb;296(2):H404-12. doi: 10.1152/ajpheart.00747.2008.

11.

Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats.

Lu J, Yao YY, Dai QM, Ma GS, Zhang SF, Cao L, Ren LQ, Liu NF.

Cardiovasc Diabetol. 2012 Sep 7;11:105. doi: 10.1186/1475-2840-11-105.

12.

K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.

Gao S, Long CL, Wang RH, Wang H.

Cardiovasc Res. 2009 Aug 1;83(3):444-56. doi: 10.1093/cvr/cvp099.

13.

Proteasome inhibition attenuates heart failure during the late stages of pressure overload through alterations in collagen expression.

Ma Y, Chen Y, Yang Y, Chen B, Liu D, Xiong Z, Zhang C, Dong Y.

Biochem Pharmacol. 2013 Jan 15;85(2):223-33. doi: 10.1016/j.bcp.2012.10.025.

PMID:
23142711
14.

Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.

Li CJ, Lv L, Li H, Yu DM.

Cardiovasc Diabetol. 2012 Jun 19;11:73. doi: 10.1186/1475-2840-11-73.

15.

Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy.

Perlini S, Palladini G, Ferrero I, Tozzi R, Fallarini S, Facoetti A, Nano R, Clari F, Busca G, Fogari R, Ferrari AU.

Hypertension. 2005 Nov;46(5):1213-8.

16.

[Effects of losartan, ramipril and their combination on left ventricular remodeling and function in spontaneous hypertensive rats].

Xu R, Zhang Y, Zhang M, Li XC, Cai H, Chen WQ, Zhu H, Ge ZM, Zhang W.

Zhonghua Yi Xue Za Zhi. 2005 Nov 30;85(45):3199-204. Chinese.

PMID:
16405840
17.

Long-term oral Asperosaponin VI attenuates cardiac dysfunction, myocardial fibrosis in a rat model of chronic myocardial infarction.

Li C, Gao Y, Tian J, Xing Y, Zhu H, Shen J.

Food Chem Toxicol. 2012 May;50(5):1432-8. doi: 10.1016/j.fct.2012.01.024.

PMID:
22343037
18.

Hydrogen sulfide suppresses the expression of MMP-8, MMP-13, and TIMP-1 in left ventricles of rats with cardiac volume overload.

Zhang CY, Li XH, Zhang T, Fu J, Cui XD.

Acta Pharmacol Sin. 2013 Oct;34(10):1301-9. doi: 10.1038/aps.2013.84.

19.

N-acetyl-Ser-Asp-Lys-Pro inhibits interleukin-1β-mediated matrix metalloproteinase activation in cardiac fibroblasts.

Rhaleb NE, Pokharel S, Sharma UC, Peng H, Peterson E, Harding P, Yang XP, Carretero OA.

Pflugers Arch. 2013 Oct;465(10):1487-95. doi: 10.1007/s00424-013-1262-8.

20.

Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload.

Ruetten H, Dimmeler S, Gehring D, Ihling C, Zeiher AM.

Cardiovasc Res. 2005 Jun 1;66(3):444-53.

Items per page

Supplemental Content

Support Center